Clinical Trials Transparency
Join us on May 12 as we survey the international clinical trial transparency landscape and data reporting requirements of academic researchers and the biopharmaceutical industry.
About the Past Event
Clinical Trial Transparency, also known as Data Disclosure & Transparency, is a compliance requirement mandated by various international laws and policies involving registering clinical study protocol information on publicly accessible databases, disseminating clinical study results, and sharing of clinical trial data sets in support of biomedical innovation, increasing awareness in clinical research, and providing transparency in pharmaceutical research and healthcare innovation. This webinar surveys the international clinical trial transparency landscape and data reporting requirements of academic researchers and the biopharmaceutical industry.
Learning Objectives:
- Overview of Clinical Trial Transparency and the international regulatory landscape.
- Understanding of basic international requirements, including what is required for registering studies on public databases, posting results of studies when completed, and generating plain language summary results for patients and the general public.
Speaking at the event
Erik Lakes, MSc, MScRA
Senior Director of Data Disclosure and Transparency, BeiGene
Erik Lakes has over fifteen years of experience working in the biopharmaceutical industry. He is the Senior Director and Head of Data Disclosure and Transparency for BeiGene, Ltd., where he is responsible for trial disclosure and data transparency compliance worldwide. Prior to joining BeiGene, Erik...
Learn more about Erik
